Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Intravítrea de bevacizumab en...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Intravítrea de bevacizumab en el edema macular secundario a oclusión venosa de rama retiniana

Intravítrea de bevacizumab en el edema macular secundario a oclusión venosa de rama retiniana

Bibliographic Details
Main Authors: Caridad Chiang Rodríguez, Raúl Rúa Martínez, Silvio Llanes Domínguez, Yusimik Toledo González, Suzel Lapido Polanco, Waldemar Baldoquín Rodríguez
Format: Article
Language:Spanish
Published: Editorial Ciencias Médicas
Series:Revista Cubana de Oftalmología
Subjects:
anti-vegf
retina
bevacizumab
avastin
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762014000300008&lng=en&tlng=en
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1561-3070

Similar Items

  • Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity
    by: Anthony A. Jones, et al.
    Published: (2024-12-01)
  • The Advantage of Bevacizumab in Treating Colorectal Brain Metastasis
    by: Hung-Ming Chen, et al.
    Published: (2014-09-01)
  • Tremendous result of bevacizumab in malignant hypertensive retinopathy
    by: Ali M Al-Halafi
    Published: (2015-01-01)
  • Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study
    by: M.   Yu. Fedyanin, et al.
    Published: (2021-06-01)
  • A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
    by: Kai Huang, et al.
    Published: (2021-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs